Remove Documentation Remove Patient Care Remove Presentation
article thumbnail

Deucravacitinib Shows Joint, Skin Symptom Improvements in Psoriatic Arthritis

Drug Topics

POETYK PsA-1 is a randomized, double-blind, placebo-controlled phase 3 trial evaluating the efficacy and safety of deucravacitinib compared to placebo in adult patients with PsA who are naïve to biologic disease-modifying anti-rheumatic medications. of patients who received placebo. References 1.

article thumbnail

Netty Cracknell on the current state and future trajectory of pharmacy in cancer services

Hospital Pharmacy Europe

Development and collaboration in oncology pharmacy An emerging opportunity lies in the integration of advanced technologies such as precision medicine and artificial intelligence (AI) to optimise patient care. On a global scale, Netty believes the growing use of biosimilars presents a significant opportunity to improve patient care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

Artificial intelligence (AI) platforms such as PGxAI are now automating literature review, guideline development, and reimbursement documentation, enabling pharmacogenetic innovation to move from discovery to clinical application in months rather than decades.

article thumbnail

CDC Report Finds No Connection Between Thimerosal and Autism

Drug Topics

The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines. These include Afluria (multidose presentation), Flucelvax (multidose presentation), and Fluzone (multidose presentation), all with a 0.01% concentration of thimerosal.

article thumbnail

What is Digital Communication: Comprehensive Explanation with Examples

Viseven

Benefits of Digital Communication for Patient Care Digital communication isn’t just an upgrade to how we manage health, it’s a transformation. It’s breaking down barriers, creating new possibilities, and putting patients at the center of care like never before. But this challenge presents a great opportunity.

article thumbnail

From Pasteur to Present: Historical and Contemporary Perspectives on Publication Bias in Scientific Literature

Pharmacy Times

Geison’s findings, which draw on Pasteur’s previously inaccessible laboratory notebooks, offer detailed documentation of how public scientific claims may be shaped by selective presentation of data. This has practical consequences for patient care, policy development, and the evaluation of novel interventions.

article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

Despite a high prevalence of childhood and youth-aged obesity, the use of medications for treating obesity is persistently low among children and young adults (YA), according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. References 1.